Orbimed Advisors - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$50,897,520
-38.6%
1,338,000
+47.0%
1.08%
-28.0%
Q2 2023$82,919,220
+38.1%
910,2000.0%1.50%
+27.4%
Q1 2023$60,036,792
+4340.6%
910,200
+1702.9%
1.18%
+5026.1%
Q1 2020$1,352,000
-91.0%
50,485
-91.9%
0.02%
-91.9%
Q3 2019$15,029,000
-68.8%
623,859
-67.1%
0.28%
-61.7%
Q2 2019$48,114,000
+34.3%
1,898,700
+3.3%
0.74%
+34.2%
Q1 2019$35,828,000
+730.7%
1,837,300
+461.9%
0.56%
+593.8%
Q4 2018$4,313,000327,0000.08%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders